Experts discuss how obstetric and pediatric clinicians can coordinate to protect newborns.
|Articles|November 2, 2011
DailyDx: What is the Diagnosis of this Uterus?
Author(s)Joe Antony, MD
Test your ob/gyn knowledge in our DailyDx.
Advertisement
What do you think is being demonstrated in this image of the uterus?
What's your diagnosis?
This image demonstrates a double decidual sac sign.
We challenge you to stump your colleagues!
Advertisement
Related to this article
Experts review ACOG's 2026-27 guidance and the RSV window extension for pregnant and postpartum patients.
On September 9, 2026, certolizumab pegol received FDA Breakthrough Therapy Designation for APS pregnancy; Jane E. Salmon, MD, reviews the IMPACT trial results behind it.
SUID was the largest single contributor to the Black-White infant mortality gap in 2024 and drove the biggest share of its rise since 2020.
Garima Sharma, MD, outlines validated cardiac risk scores for antenatal screening and the postpartum transitions needed to keep high-risk patients from being lost to follow-up.
Anti-CGRP antibody exposure in early pregnancy was linked to higher spontaneous abortion risk; propranolol was not.
Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.
HPV vaccination before pregnancy was linked to lower odds of preterm birth in a Swedish study of 624,713 births.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Jane E. Salmon, MD, on the IMPACT trial of certolizumab pegol for adverse pregnancy outcomes in APS
2
SUID drives widening Black-White infant mortality gap since 2020
3
Anti-CGRP antibodies associated with higher spontaneous abortion risk
4
What ACOG's 2026-27 respiratory virus guidance means in practice
5